Brief: ChromaDex Signs Sinopharm Xingsha Agreement To Accelerate Cross-Border Sales Of Tru Niagen Into Mainland China
10/06/2022 11:36
June 10 (Reuters) - Chromadex Corp CDXC.O :
* CHROMADEX SIGNS SINOPHARM XINGSHA AGREEMENT TO ACCELERATE
CROSS-BORDER SALES OF TRU NIAGEN® INTO MAINLAND CHINA
* CHROMADEX CORP - UNDER DISTRIBUTION AGREEMENT, ALL
CROSS-BORDER
OPERATIONS IN REGION WILL BE TRANSITIONED TO SINOPHARM
Source text for Eikon: ID:nBw3gfSN0a
Further company coverage: CDXC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce